Geir Harald Mjøen

  • Consultant; MD, PhD
 

Publications 2022

Gandolfini I, Crespo M, Hellemans R, Maggiore U, Mariat C, Mjoen G, Oniscu GC, Peruzzi L, Sever MS, Watschinger B, Hilbrands L (2022)
Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group
Nephrol Dial Transplant, 37 (10), 1824-1829
DOI 10.1093/ndt/gfac203, PubMed 35746885

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisæter AV, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2022)
Increased risk of ischaemic heart disease after kidney donation
Nephrol Dial Transplant, 37 (5), 928-936
DOI 10.1093/ndt/gfab054, PubMed 33624826

Mariat C, Mjøen G, Watschinger B, Sever MS, Crespo M, Peruzzi L, Oniscu GC, Abramowicz D, Hilbrands L, Maggiore U (2022)
Assessment of pre-donation glomerular filtration rate: going back to basics
Nephrol Dial Transplant, 37 (3), 430-437
DOI 10.1093/ndt/gfab259, PubMed 34519827

Publications 2021

Bjørkto MH, Barratt-Due A, Nordøy I, Dörje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjøen G (2021)
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
BMC Infect Dis, 21 (1), 137
DOI 10.1186/s12879-021-05789-2, PubMed 33526010

Dahle DO, Mjøen G (2021)
Hypertensive Living Kidney Donor Candidates: What's the Risk?
Kidney Int Rep, 6 (5), 1208-1210
DOI 10.1016/j.ekir.2021.03.891, PubMed 34015066

Delanaye P, Gaillard F, van der Weijden J, Mjøen G, Ferhman-Ekholm I, Dubourg L, Ebert N, Schaeffner E, Åkerfeldt T, Goffin K, Couzi L, Garrouste C, Rostaing L, Courbebaisse M, Legendre C, Hourmant M, Kamar N, Cavalier E, Weekers L, Bouquegneau A, de Borst MH, Mariat C, Pottel H, van Londen M (2021)
Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
Clin Chem Lab Med, 60 (3), 401-407
DOI 10.1515/cclm-2021-1011, PubMed 34670031

Haugen AJ, Mjøen G (2021)
Living donation - any news on the donor?
Curr Opin Organ Transplant, 26 (1), 85-90
DOI 10.1097/MOT.0000000000000830, PubMed 33278148

Langberg NE, Jenssen TG, Haugen AJ, Mjøen G, Birkeland KI, Åsberg A, Hartmann A, Dahle DO (2021)
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
Transplant Direct, 8 (1), e1262
DOI 10.1097/TXD.0000000000001262, PubMed 34912949

Mjøen G, Maggiore U, Kessaris N, Kimenai D, Watschinger B, Mariat C, Sever MS, Crespo M, Peruzzi L, Spasovski G, Sørensen SS, Heemann U, Pascual J, Viklicky O, Courtney AE, Hadaya K, Wagner L, Nistor I, Hadjianastassiou V, Durlik M, Helanterä I, Oberbauer R, Oniscu G, Hilbrands L, Abramowicz D (2021)
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
Nephrol Dial Transplant, 36 (9), 1742-1753
DOI 10.1093/ndt/gfab035, PubMed 33585931

Publications 2020

Benoni H, Eloranta S, Dahle DO, Svensson MHS, Nordin A, Carstens J, Mjøen G, Helanterä I, Hellström V, Enblad G, Pukkala E, Sørensen SS, Lempinen M, Smedby KE (2020)
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Transpl Int, 33 (12), 1700-1710
DOI 10.1111/tri.13734, PubMed 32896035

Bjerre A, Mjøen G, Line PD, Naper C, Reisaeter AV, Åsberg A (2020)
Five decades with grandparent donors: The Norwegian strategy and experience
Pediatr Transplant, 24 (6), e13751
DOI 10.1111/petr.13751, PubMed 32485019

Dahle DO, Mjoen G (2020)
The Salutary Blood Pressure of a Solitary Kidney
Am J Hypertens, 33 (3), 218-219
DOI 10.1093/ajh/hpaa004, PubMed 31907513

Haller MC, Wallisch C, Mjøen G, Holdaas H, Dunkler D, Heinze G, Oberbauer R (2020)
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study
Transpl Int, 33 (7), 729-739
DOI 10.1111/tri.13580, PubMed 31970822

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl Int, 33 (5), 536-543
DOI 10.1111/tri.13576, PubMed 31958170

Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B (2020)
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
Nephrol Dial Transplant, 35 (6), 899-904
DOI 10.1093/ndt/gfaa130, PubMed 32441741

Pihlstrøm HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarström C, Kasprzycka M, Wang J, Haraldsen G, Mjøen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H (2020)
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
PLoS One, 15 (12), e0243759
DOI 10.1371/journal.pone.0243759, PubMed 33326471

Thorsteinsdottir H, Salvador CL, Mjøen G, Lie A, Sugulle M, Tøndel C, Brun A, Almaas R, Bjerre A (2020)
Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation
Dis Markers, 2020, 6162892
DOI 10.1155/2020/6162892, PubMed 32089755

Åsberg A, Bergan S, Bjørkto MH, Mjøen G, Varberg Reisæter A, Robertsen I, Midtvedt K (2020)
Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient-No Intervention Actually Needed
Transplant Direct, 6 (10), e609
DOI 10.1097/TXD.0000000000001058, PubMed 33062842

Publications 2019

Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316

Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl Int, 32 (9), 960-964
DOI 10.1111/tri.13443, PubMed 30983060

Mjoen G, Abramowicz D (2019)
What happens to the live donor in the years following donation?
Nephrol. Dial. Transplant., 34 (8), 1289-1291
DOI 10.1093/ndt/gfy356

Mjoen G, Reisæter A, Hartmann A, Dahle DO, Holdaas H (2019)
Regarding age-calibrated glomerular filtration rate
Kidney Int, 95 (1), 234-235
DOI 10.1016/j.kint.2018.10.003, PubMed 30606421

Publications 2018

Mjoen G, Holdaas H (2018)
Mid- and Long-Term Health Risks in Living Kidney Donors
Ann Intern Med, 169 (4), 265
DOI 10.7326/L18-0340, PubMed 30128523

Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, Dahle DO, Holdaas H, Melum E (2018)
Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
Am J Transplant, 19 (5), 1444-1451
DOI 10.1111/ajt.15191, PubMed 30457209

Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
Nephrol Dial Transplant, 33 (1), 102-112
DOI 10.1093/ndt/gfw360, PubMed 27798199

Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation, 101 (10), 2599-2605
DOI 10.1097/TP.0000000000001659, PubMed 28207636

Holdaas H, Mjøen G, Jardine AG (2017)
Belatacept: Where the BENEFITS Outweigh the Risk
Am J Kidney Dis, 69 (5), 561-563
DOI 10.1053/j.ajkd.2017.02.007, PubMed 28434523

Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
Ann Transplant, 22, 148-155
DOI 10.12659/aot.902330, PubMed 28321111

Mjøen G, Holdaas H (2017)
Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
Kidney Int, 91 (5), 1256
DOI 10.1016/j.kint.2017.01.034, PubMed 28407879

Mjøen G, Holdaas H (2017)
Long term risk of mortality after living kidney donation
BMJ, 357, j1770
DOI 10.1136/bmj.j1770, PubMed 28442509

Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K (2017)
Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
Lupus, 26 (8), 881-885
DOI 10.1177/0961203316686700, PubMed 28059018

Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl Int, 30 (8), 827-840
DOI 10.1111/tri.12973, PubMed 28436117

Publications 2016

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin Transplant, 30 (7), 802-9
DOI 10.1111/ctr.12753, PubMed 27101801

Mjoen G, Reisaeter AV, Dahle DO (2016)
HLA Mismatch and Allograft Survival
Transplantation, 100 (9), e52
DOI 10.1097/TP.0000000000001366, PubMed 27399204

Mjøen G, Holdaas H (2016)
Regarding long-term outcome after kidney donation
Transpl Int, 29 (3), 381
DOI 10.1111/tri.12717, PubMed 26563683

Mjøen G, Holdaas H (2016)
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
N Engl J Med, 374 (21), 2094
DOI 10.1056/NEJMc1603007, PubMed 27223156

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 31 (1), 170
DOI 10.1093/ndt/gfv397, PubMed 26740671

Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
Am J Transplant, 17 (2), 528-533
DOI 10.1111/ajt.13995, PubMed 27483393

Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol, 17 (1), 148
DOI 10.1186/s12882-016-0373-9, PubMed 27760523

Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
Am J Transplant, 17 (1), 265-271
DOI 10.1111/ajt.13933, PubMed 27341702

Publications 2015

Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-7
DOI 10.1097/TP.0000000000000660, PubMed 25757216

Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Clin Transplant, 29 (3), 268-76
DOI 10.1111/ctr.12515, PubMed 25644963

Mjøen G, Holdaas H (2015)
The authors reply:
Kidney Int, 87 (3), 660
DOI 10.1038/ki.2014.400, PubMed 25723634

Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
Transplantation, 99 (2), 351-9
DOI 10.1097/TP.0000000000000583, PubMed 25594550

Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
Transplantation, 99 (4), 791-6
DOI 10.1097/TP.0000000000000422, PubMed 25222012

Publications 2014

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
DOI 10.1111/ctr.12435, PubMed 25124959

Holdaas H, Mjoen G (2014)
Long-term risks of kidney donation: age known
Am J Transplant, 14 (11), 2671-2
DOI 10.1111/ajt.12971, PubMed 25293790

Mjøen G (2014)
The author replies
Kidney Int, 85 (6), 1469
DOI 10.1038/ki.2014.91, PubMed 24875550

Mjøen G, Hallan S, Dekker FW, Holdaas H (2014)
The authors reply
Kidney Int, 86 (3), 650
DOI 10.1038/ki.2014.148, PubMed 25168504

Mjøen G, Hallan S, Holdaas H (2014)
The authors reply:
Kidney Int, 85 (5), 1241-2
DOI 10.1038/ki.2014.37, PubMed 24786884

Mjøen G, Holdaas H (2014)
The authors reply
Kidney Int, 86 (2), 447
DOI 10.1038/ki.2014.149, PubMed 25079028

Mjøen G, Holdaas H (2014)
Selecting appropriate controls for kidney donors
Am J Transplant, 15 (1), 286
DOI 10.1111/ajt.13016, PubMed 25363214

Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
DOI 10.1097/TP.0000000000000205, PubMed 24999963

Publications 2013

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
DOI 10.1111/ctr.12290, PubMed 24372653

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
DOI 10.1038/ki.2013.460, PubMed 24284516

Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
Clin Transplant, 28 (1), 111-9
DOI 10.1111/ctr.12285, PubMed 24372612

Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M (2013)
Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
Clin Transplant, 27 (6), E636-43
DOI 10.1111/ctr.12220, PubMed 23991916

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
DOI 10.1111/ctr.12288, PubMed 24351078

Publications 2011

Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
Inflammation-associated graft loss in renal transplant recipients
Nephrol Dial Transplant, 26 (11), 3756-61
DOI 10.1093/ndt/gfr163, PubMed 21511816

Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
Age, gender, and body mass index are associated with renal function after kidney donation
Clin Transplant, 25 (6), E579-83
DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
DOI 10.1093/ndt/gfr303, PubMed 21636826

Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
Quality of life in kidney donors
Am J Transplant, 11 (6), 1315-9
DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387

Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
Rheumatology (Oxford), 50 (9), 1659-64
DOI 10.1093/rheumatology/ker186, PubMed 21624893

Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
Arthritis Rheum, 63 (3), 733-7
DOI 10.1002/art.30184, PubMed 21360503

Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H (2011)
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study
Nephrol Dial Transplant, 27 (6), 2571-5
DOI 10.1093/ndt/gfr694, PubMed 22172725

Publications 2010

Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
One- and five-year follow-ups on blood pressure and renal function in kidney donors
Transpl Int, 24 (1), 73-7
DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180

Mjøen G, Holdaas H, Pfeffer P, Line PD, Øyen O (2010)
Minimally invasive living donor nephrectomy - introduction of hand-assistance
Transpl Int, 23 (10), 1008-14
DOI 10.1111/j.1432-2277.2010.01087.x, PubMed 20412538

Publications 2009

Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
Transplantation, 88 (11), 1273-9
DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926

Page visits: 6430